AKESOgen and Identitas partner to provide a comprehensive Next Generation Forensic profiling solution New York, NY, USA and Norcross, GA, USA – August 16th 2013 – Identitas Corp., a leader in forensic phenotyping and AKESOgen, the genomics and biorepository services company today announced a global commercial partnership to offer the forensic industry […]
Share this 
AKESOgen scientists attended the 2013 BIO International Convention and were located at the Georgia Pavillion in Chicago April 22nd-25th 2013. Please email info@akesogen.com or call +1(770)542-0890 if you would like to follow up with a delegate to discuss your project or any biobanking or genomics needs. Share this
Share this 
Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules. Pradip D, Bouzyk M, Dey N, Leyland-Jones B. Am J Cancer Res. 2013 Apr 3;3(2):173-95. Print 2013. PMID: 23593540 [PubMed] Free PMC Article Share this
Share this 
AKESOgen completes 25,000 Nucleic Acid extractions in 18 months. “We are delighted to announce this important milestone in our DNA and RNA extraction services. During this time we have isolated, quantified and normalized DNA and RNA from sources as diverse as saliva, whole blood, buffy coat, buccal cells and paraffin embedded formalin fixed tissue for […]
Share this
Dr. Bouzyk presented at the Clinical Business Expo Summit at the Seaport World Trade Center, Boston, MA on September 18th 2012. Workshop entitled:Crucial Considerations to Guarantee Fit for Purpose and Project-Relevant Outcomes from your Biosample Collection: A Case-Based Approach Share this
Share this 
Share this
Share this 
Share this
Share this 
Company Profile: AKESOgen, Inc. Bouzyk M, Boisjoli R. Pharmacogenomics. 2012 Jul;13(10):1115-8. doi: 10.2217/pgs.12.87. PMID: 22909201 [PubMed – indexed for MEDLINE] Share this
Share this
AKESOgen and London Genetics International alliance to enhance drug development through pharmacogenetics and related services Norcross, GA, US and London, UK – March 29th 2012 – AKESOgen, the genomics and biorepository services company, and London Genetics International, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic […]
Share this 
CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial. Regan MM, Leyland-Jones B, Bouzyk M, Pagani O, Tang W, Kammler R, Dell’orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Neven P, Debled M, Maibach R, Price KN, Gelber RD, Coates AS, Goldhirsch A, Rae […]
Share this